Summary of advantages and disadvantages of stirred tank (suspended cells) and fixed-bed reactors (immobilized cells).
Fixed-bed processes operated in perfusion, where cells are immobilized within macroporous carriers, are a promising alternative to processes with suspended microbial or mammalian cells. Their potential has been demonstrated for many purposes. Nevertheless, the number of industrial fixed-bed processes is quite small. To some extent, this is due to the lack of process development tools for fixed-bed processes. To fill this gap, a strategy was developed for the design and evaluation of relevant process parameters of fixed-bed processes. A scale-up concept is presented in order to evaluate the performance as part of process design of fixed-bed processes. This comprises fixed-bed reactors on three different scales, the smallest being the downscaled Multiferm with 10 mL fixed-bed units, the second a 100 mL fixed-bed reactor, and the third a pilot-scale reactor with 1 L fixed-bed volume. The performance of this concept will be discussed for fixed-bed cultures of lactic acid bacteria. Furthermore, a reaction kinetic model for the design of fixed-bed reactors will be presented.
- bacterial culture
- lactic acid bacteria
Technologies for immobilization of biocatalyst, e.g., microbial or mammalian cells, are increasingly being considered for biotechnological processes due to many advantages compared to cell suspension culture such as continuous operation, accelerated reaction rates, high volumetric productivity, retention of plasmid-bearing cells, prevention of interfacial inactivation, stimulation of production and excretion of secondary metabolites, and protection against turbulent high-shear environment, reduced susceptibility of cells to contamination, improved production efficiency, and reduced risk of washout [1, 2, 3]. Especially the increased importance of productivity for industrial processes due to restriction of production time and final product volume has drawn the attention to immobilization techniques in recent years, as they allow overcoming most of the limitations of commonly applied suspension cultures . A summary of advantages and disadvantages for suspension cultures (stirred tank reactors) and immobilized cultures (fixed-bed reactors) is given in Table 1.
|Stirred tank/suspension||Known technology||Aeration difficult at high cell densities (relevant for aerobic cells)|
|Good mass transfer||Cell damage by shear and aeration (e.g., mammalian cells)|
|Good mixing||Foaming (relevant for aerobic cells)|
|Cell count possible||Low cell density and volumetric productivity|
Cell retention required for perfusion culture, techniques insufficient for long-term culture
|High potential for scale-up|
|Fixed-bed/immobilized cells||High cell density and productivity per unit||Concentration gradients|
|Easy exchange of medium||Nonhomogeneous|
|High productivity over long periods of time||Cell count impossible|
|Low-shear rates (relevant for mammalian cells)|
Various immobilization techniques such as the entrapment of cells in stable porous gels (e.g., alginate, agarose, collagen, chitosan, cellulose, κ-carrageenan, or gel-matrix polymers such as polyacrylamide-hydrazide) or hydrogels or immobilization in solid macroporous carriers have been developed and are applied in both laboratory and industrial scales for different purposes, e.g., food, dairy, and beverage industry, production of drugs, wastewater treatment, agricultural industry, and biodiesel production [2, 3, 4].
Bioreactors for immobilized biocatalyst are mostly operated continuously in perfusion mode. Here continuous stirred tank reactors with cell retention and fixed-bed (packed bed) or fluidized-bed bioreactor systems can be applied. The following remarks focus on fixed-bed reactors, which consist of a packed column of macroporous carriers wherein cells are immobilized, as they have been used very successfully for a wide range of applications . The advantages of fixed-bed reactors with immobilized cells (Table 2) are mainly with respect to general productivity and operational flexibility . The volumetric productivity of immobilized cells is generally higher than the corresponding free cell fermentations . This higher productivity can be explained by the fact that the microenvironments offered by the carrier are more stabilizing for the organisms, which generally show optimal activity only in a narrow range of physical conditions. Due to cell retention, it is possible to run fixed-bed bioreactors in a perfusion mode at a steady state with dilution rates higher than the maximum specific growth rate of the used strain. By this, very high volume-specific productivities can be reached and maintained for long periods of time and greatly facilitate recycling or reuse of microorganisms . Consequently, both the operational stability of the immobilized organisms and the productivity are improved.
Despite the obvious advantages of fixed-bed bioreactor systems, the number of industrial fixed-bed processes is quite small [2, 3, 4]. To some extent, this is due to the lack of process development tools for fixed-bed processes and meaningful concepts for design and operation of fixed-bed reactors on a large scale. To fill this gap, strategies for the design and evaluation of relevant process parameters of fixed-bed processes are required, and a scale-up concept is introduced.
In the following, the characteristics of fixed-bed bioreactors as well as a design concept for layout and scale-up will be introduced. Examples for macroporous carriers will be given. The design strategy for fixed-bed reactors will be discussed in detail for immobilized cultures of lactic acid-producing bacteria (LABs). Finally, a reaction kinetic model is introduced which allows evaluation of the culture performance. Conclusions complete the text.
2. Fixed-bed reactor systems
Fixed-bed bioreactors consist of a mostly cylindrical column containing macroporous carriers, wherein cells are immobilized (Figure 1A). The column is permanently perfused with fresh medium [4, 7]. If required, the medium can be circulated in a loop (Figure 1B). This might be useful if appropriate flow rates and medium supply rates vary significantly.
For small fixed-bed volumes with a height of approximately 10 cm, the medium can be pumped axially through the bed. In this case, at the outlet the oxygen concentration in the case of aerobic cells, e.g., mammalian cells , or the pH in the case of acid-producing anaerobic cells, e.g., LABs , should remain in a physiological range. A further increase of the length would result in too low oxygen or pH values in the upper zones of the bed. This can be overcome by applying a radial medium flow as shown in Figure 1C, where the radius determines the length of the oxygen or pH gradient, not the height of the column. This concept was successfully applied for mammalian cell culture  and lactic acid bacteria, as discussed in the following.
Cell immobilization in fixed-bed reactors with macroporous carriers is fairly simple compared to other methods such as entrapping in gels (e.g., alginate). Cell loading is often carried out by simply pumping a cell suspension through the bed of carriers, and cells are kept under same physiological conditions for the immobilization. As only the natural properties of the surface and cells interact, there are no toxic effects arising from activating reagents compared to cell entrapment within polymers. Additionally, high load of cells can be avoided by desorption of cells from the solid surface to the cell suspension.
2.2 Concept for design and operation
Process parameters that have to be optimized during process development comprise selection of carriers, medium selection, appropriate flow velocity, and long-term performance, among others. All these information are required to evaluate the overall performance, e.g., productivity, and to layout the scale-up strategy. In the following, a platform for development of processes for immobilized cells is introduced (Figure 2). As a start, suitability of different carriers can be compared in a small-scale multi-well system. After this, bioreactor systems of different sizes can be used to work out the required process parameters. The first, very small scale of 10 mL working volume is the multi-fixed-bed bioreactor “Multiferm” . The next step is an axial-flow 100 mL fixed-bed system, which can be operated continuously with reasonable effort to investigate the performance and long-term stability of the culture . As a first approach for scale-up, a radial-flow 1 L fixed-bed reactor is applied [6, 10]. Even if this is probably not the final industrial scale, the reactor system has already been the main characteristics of a large-scale system, mainly the radius. For further increase of the volume, just the height has to be increased . For all three systems, a “proof of concept” has been shown before . In Chapter 4 the performance of these three fixed-bed systems is compared for fixed-bed cultures of LABs.
In cell immobilization, properties of the carrier materials play an important role. This type of immobilization on solid synthetic materials firstly has the advantage that the microorganisms attach independently to the carrier (interaction with the surface) and thus no additional process steps and reagents are required for immobilization. At this point, carrier materials have to demonstrate several certain characteristics. Atkinson et al.  and Pörtner and Märkl  summarized these properties for cell immobilization such as simple and nontoxic material, high cell loading capacity, mechanical stability, stable at appropriate operational pH values, autoclavable, resistant to microbial degradation, cost appropriate to the application, density appropriate to reactor type used, as well as reusable, if possible. Examples are given in [4, 6]. In our own studies, carriers made of glass [Siran (QVF, Mainz, Germany), VitraPOR® (ROBU® Glasfilter-Geräte GmbH)] or ceramics [(CERAMTEC EO 19/30 (CeramTec, Marktredwitz, Germany) (Figure 3) or Sponceram (Zellwerk, Oberkrämer, Germany)] were applied. All carriers showed similar results with respect to immobilized cell density and lactic acid productivity for immobilized LAB strains .
4. Case study: fixed-bed cultivation of LAB strains
4.1 Overview on immobilization techniques used for LAB strains
Lactic acid bacteria are commonly used in the production of fermented dairy products as well as for production of lactic acid, antimicrobial substances (bacteriocins), and biodegradable polymers, among others [13, 14, 15]. Industrial processes use mostly conventional batch or fed-batch fermentation with suspended cells. Reactor volumes go up to 100 m3, and process time varies between several hours and days depending on the strain and the process strategy . Even if high cell and product concentrations can be reached, the known drawbacks such as low productivity, product inhibition, and also the variation from batch to batch remain [16, 17, 18].
Since the immobilization of LAB has many advantages, it has been examined extensively, e.g., for the production of lactic acid; the production of starter cultures; the production of bacteriocins, e.g., nisin; and the formation of aromatic compounds (reviewed in ). Different methods have been used for immobilizing LAB: physical entrapment in polymeric networks, microencapsulation, attachment or adsorption to a carrier, and membrane entrapment . The purpose of all these techniques is either to keep high cell concentrations within the bioreactor or to protect cells from a hostile environment. In many applications of cell entrapment, droplets of thermal (κ-carrageenan, gellan, agarose, gelatin) or ionotropic (alginate, chitosan) gels are used to produce spherical gel biocatalysts, and these controlled-size polymer droplets are produced using extrusion or emulsification, under mild conditions (reviewed in ). However, although promising on a laboratory scale, the large-scale production of beads under aseptic conditions still has difficulties .
Another immobilization technique is to immobilize LAB cells onto solid macroporous carriers and apply these in fixed-bed bioreactors. Examples are given in . In the following, our recent work in this area will be discussed.
4.2 Fixed-bed cultures of LAB strains
4.2.1 Examples for fixed-bed cultivation on different scales
For all three fixed-bed bioreactor systems (
The volume-specific lactic acid and cell productivity increased with increasing perfusion rate (see below).
Parallel cultivation in the
The microbiological and mechanical stabilities of continuous cultivations during prolonged fermentations are critical properties of an immobilized cell process, and industrial applications are largely dependent on these properties. Therefore, we focused on the examination of long-term (52 days) continuous cultivation of
The scale-up from 100 mL to 1 L fixed-bed (Figure 5) was successful, as similar productivities could be obtained in both systems (see below). As a conclusion, the continuous cultivation of immobilized LAB strains in fixed-bed reactors shows a high biological stability as well as cell and lactate production in long-term fermentation.
4.2.2 Comparison of suspension and fixed-bed systems on different scales
Fixed-bed and suspension cultures of
For the fixed-bed-cultures, the productivity increases further due to cell retention in the carriers. The highest value determined here is approx. 3–4 times higher than the maximum in chemostat cultivation. Obviously the maximum for fixed-bed cultures has not been reached so far.
All fixed-bed systems used here can be described by the same spline. This is very important with respect to scale-up, as obviously data from small-scale systems can be used to predict the performance on a larger scale (for more details on scale-up, see ).
4.3 Reaction kinetic model for start-up of fixed-bed reactors
For establishment of mathematical process model, biomass formation, lactose consumption, and lactate production during start-up of fixed-bed cultures with immobilized
The goal of the studies was to evaluate the performance of fixed-bed bioreactor systems on different scales compared to suspension culture. The suggested concept for development of fixed-bed processes could be confirmed. The multi-fixed-bed bioreactor
As expected, fixed-bed bioreactors could be operated in a perfusion mode at a steady state with dilution rates higher than the maximum specific growth rate. By this, very high volume-specific productivity with respect to lactate can be reached and maintained for long periods of time. The fixed-bed processes with lactic acid bacteria on macroporous carriers could be transferred on a pilot scale without loss in productivity. Furthermore, the productivity could be described by a spline, indicating that the maximum growth rate was not reached in this study.
Therefore, a process development tool for fixed-bed processes is now at hand that will pave the way for an industrial application of this promising technology.
Abbreviations and symbols
|D||Dilution rate (h−1)|
|F||Flow rate (L·h−1)|
|Fin||Inlet flow rate (L·h−1)|
|Fout||Outlet flow rate (L·h−1)|
|klys||Lysis rate (h−1)|
|KS||Substrate saturation constant (g·L−1)|
|LAB||Lactic acid bacteria|
|mr||Maintenance rate of retained cells (h−1)|
|Pout||Product concentration at the outlet (g·L−1)|
|R||Fraction of retained biomass in perfusion fermentation (−)|
|S||Substrate concentration (g·L−1)|
|Sin||Substrate concentration at the inlet (g·L−1)|
|Sout||Substrate concentration at the outlet (g·L−1)|
|Xf||Free suspended biomass concentration (g·L−1)|
|Xf,out||Free suspended biomass concentration at the outlet (g·L−1)|
|Xr||Retained biomass concentration (g·L−1)|
|Yj||Concentration of either biomass, substrate, or product (g·L−1)|
|YX/S||Biomass yield coefficient from substrate (g·g−1)|
|α||Growth-associated product formation rate (g·g−1)|
|β||Nongrowth-associated product formation rate (h−1)|
|γ||Constant for unspecific substrate loss (L·g−1·h−1)|
|μ||Specific growth rate (h−1)|
|μmax||Maximum specific growth rate (h−1)|
|ηP||Effectiveness factor production (−)|
Tramper J. Conversions by immobilized cells versus traditional fermentations. In: Bont JAM, Visser J, Mattiasson B, Tramper J, editors. Physiology of Immobilized Cells. Amsterdam: Elsevier Science Publishers; 1989. pp. 115-126
Eş I, Vieira JDG, Amaral AC. Principles, techniques, and applications of biocatalyst immobilization for industrial application. Applied Microbiology and Biotechnology. 2015; 99(5):2065-2082. DOI: 10.1007/s00253-015-6390-y
Polakovič M, Švitel J, Bučko M, Filip J, Neděla V, Ansorge-Schumacher MB, et al. Progress in biocatalysis with immobilized viable whole cells: Systems development, reaction engineering and applications. Biotechnology Letters. 2017; 39(5):667-683. DOI: 10.1007/s10529-017-2300-y
Sen P, Nath A, Bhattacharjee C. Packed-bed bioreactor and its application in dairy, food and beverage industry. In: Larroche C, Sanroman MA, Du G, Pandey A, editors. Current Developments in Biotechnology and Bioengineering: Bioprocesses, Bioreactors and Controls. Amsterdam: Elsevier; 2017. DOI: 10.1016/B978-0-444-63663-8.00009-4
Pörtner R, Märkl H. Festbettreaktoren für die Kultivierung tierischer Zellen. BIOforum. 1995; 18:449-452
Pörtner R, Faschian R, Goelling D. Fermentation of lactic acid bacteria: State of the art and new perspectives. In: Hilterhaus L, Liese A, Kettling U, Antranikian G, editors. Applied Biocatalysis. From Fundamental Science to Industrial Applications. Weinheim: Wiley-VCH Verlag GmbH; 2016, ISBN 978-3-527-33669-2
Pörtner R, Seemuk M, Schlothauer R-C, Elsser D. Anaerobe Kultivierung von Lactococcus lactisim Festbettreaktor. Chemie Ingenieur Technik. 2004; 76(10):1599-1602
Fassnacht D, Pörtner R. Experimental and theoretical considerations on oxygen supply for animal cell growth in fixed bed reactors. Journal of Biotechnology. 1999; 72(3):169-184
Faschian R, De S, Pörtner R. Multi-fixed-bed bioreactor system applied for bioprocess development of immobilized lactic acid bacteria. The Open Biotechnology Journal. 2016; 10:1-9. DOI: 10.2174/1874070701610010001
Faschian R, Eren I, Minden S, Pörtner R. Evaluation of fixed-bed cultures with immobilized Lactococcus lactis ssp. lactison different scales. The Open Biotechnology Journal. 2017; 11:16-25. DOI: 10.2174/1874070701711010016
Pörtner R, Platas OB, Fassnacht D, Nehring D, Czermak P, Märkl H. Fixed-bed reactors for the cultivation of mammalian cells: Design, performance and scale-up. Open Biotechnology Journal. 2007; 1:41-46
Atkinson B, Black GM, Pinches A. Process intensification using cell support systems. Process Biochemistry. 1980; 15:24-32
Mayo B, Aleksandrzak-Piekarczyk T, Fernndez M, Kowalczyk M, et al. Updates in the metabolism of lactic acid bacteria. In: Mozzi F, Raya RR, Vignolo GM, editors. Biotechnology of Lactic Acid Bacteria: Novel Applications. Oxford, U.K: Wiley-Blackwell; 2010. pp. 3-33
Chahal SP. Lactic acid. In: Ullmann’s Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH; 2002
Wee YJ, Kim JN, Ryu HW. Biotechnological production of lactic acid and its recent applications. Food Technology and Biotechnology. 2006; 44(2):163-172
Zhang Y, Cong W, Shi SY. Application of a pH feedback-controlled substrate feeding method in lactic acid production. Applied Biochemistry and Biotechnology. 2010; 162(8):2149-2156
Bai DM, Wei Q, Yan ZH, Zhao XM, Li XG, Xu SM. Fed-batch fermentation of Lactobacillus lactisfor hyper-production of L-lactic acid. Biotechnology Letters. 2003; 25(21):1833-1835
Ding S, Tan T. L-lactic acid production by Lactobacillus caseifermentation using different fed-batch feeding strategies. Process Biochemistry. 2006; 41:1451-1454
Lacroix C, Grattepanche F, Doleyres Y, Bergmaier D. Immobilised cell technologies for the dairy industry. In: Nedović V, Willaert R, editors. Applications of Cell Immobilisation Biotechnology. Heidelberg: Springer; 2005. pp. 295-319
Hass V, Pörtner R. Praxis der Bioprozesstechnik. 2nd ed. Heidelberg, Germany: Spektrum Akademischer Verlag; 2011
Faschian R, Minden S, Pörtner R. Experimental investigation and reaction kinetics modeling of biomass formation, substrate consumption and product formation during start-up of fixed-bed cultures with immobilized Lactococcus lactis ssp. Lactis. Journal of Bioprocessing and Biotechniques. 2016; 6:9. DOI: 10.4172/2155-9821.1000294